OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Showing 16 citing articles:
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population
Akihiro Kuma, Akihiko Kato
Nutrients (2022) Vol. 14, Iss. 18, pp. 3787-3787
Open Access | Times Cited: 30
Akihiro Kuma, Akihiko Kato
Nutrients (2022) Vol. 14, Iss. 18, pp. 3787-3787
Open Access | Times Cited: 30
Cardiovascular-kidney-metabolic syndrome – An integrative review
Katiana Simões Kittelson, Arquimedes Gasparotto, Natasha Fillmore, et al.
Progress in Cardiovascular Diseases (2024) Vol. 87, pp. 26-36
Closed Access | Times Cited: 5
Katiana Simões Kittelson, Arquimedes Gasparotto, Natasha Fillmore, et al.
Progress in Cardiovascular Diseases (2024) Vol. 87, pp. 26-36
Closed Access | Times Cited: 5
Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease
Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg, et al.
Clinical Journal of the American Society of Nephrology (2023)
Open Access | Times Cited: 13
Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg, et al.
Clinical Journal of the American Society of Nephrology (2023)
Open Access | Times Cited: 13
Emirates consensus recommendations on cardiovascular risk management in type 2 diabetes
Hani Sabbour, Wael Almahmeed, Fatheya Alawadi, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Hani Sabbour, Wael Almahmeed, Fatheya Alawadi, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetes
Cheli Melzer Cohen, Ofri Mosenzon, Alona Aharonovich, et al.
Diabetes Research and Clinical Practice (2025), pp. 112086-112086
Closed Access
Cheli Melzer Cohen, Ofri Mosenzon, Alona Aharonovich, et al.
Diabetes Research and Clinical Practice (2025), pp. 112086-112086
Closed Access
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
Meir Schechter, Cheli Melzer Cohen, Alisa Fishkin, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Meir Schechter, Cheli Melzer Cohen, Alisa Fishkin, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Preliminary investigation on impact of intergenerational treatment of resveratrol endorses the development of ‘super-pups’
Arun K. Sharma, Monalisa Mukherjee, Ashish Kumar, et al.
Life Sciences (2022) Vol. 314, pp. 121322-121322
Closed Access | Times Cited: 11
Arun K. Sharma, Monalisa Mukherjee, Ashish Kumar, et al.
Life Sciences (2022) Vol. 314, pp. 121322-121322
Closed Access | Times Cited: 11
The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?
Theocharis Koufakis, Ioanna Zografou, Michael Doumas, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 6, pp. 601-608
Closed Access | Times Cited: 5
Theocharis Koufakis, Ioanna Zografou, Michael Doumas, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 6, pp. 601-608
Closed Access | Times Cited: 5
Diagnosing Arterial Stiffness in Pregnancy and Its Implications in the Cardio-Renal-Metabolic Chain
Vladiana Turi, Constantin Luca, Dan Gaiţă, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2221-2221
Open Access | Times Cited: 8
Vladiana Turi, Constantin Luca, Dan Gaiţă, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2221-2221
Open Access | Times Cited: 8
Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD)
Maria Svensson, Navdeep Tangri, Johan Bodegård, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 1
Maria Svensson, Navdeep Tangri, Johan Bodegård, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 1
Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia
Walaa Mohammedsaeed, Zain Alghamdi
Saudi Medical Journal (2024) Vol. 45, Iss. 7, pp. 675-684
Open Access | Times Cited: 1
Walaa Mohammedsaeed, Zain Alghamdi
Saudi Medical Journal (2024) Vol. 45, Iss. 7, pp. 675-684
Open Access | Times Cited: 1
Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide
Subodh Verma, Francesco Cosentino, Mikhail Kosiborod
European Heart Journal (2024)
Open Access | Times Cited: 1
Subodh Verma, Francesco Cosentino, Mikhail Kosiborod
European Heart Journal (2024)
Open Access | Times Cited: 1
Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
Alexei Mikhailov, Yixi Liu, Heng-Jie Cheng, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11653-e11653
Open Access | Times Cited: 4
Alexei Mikhailov, Yixi Liu, Heng-Jie Cheng, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11653-e11653
Open Access | Times Cited: 4
Risk of hospitalization with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real‐world data
Meir Schechter, Cheli Melzer Cohen, Tamir Zelter, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 10, pp. 3054-3058
Open Access | Times Cited: 2
Meir Schechter, Cheli Melzer Cohen, Tamir Zelter, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 10, pp. 3054-3058
Open Access | Times Cited: 2
Sodium-Glucose Cotransporter-2 Inhibitors: Who, When & How? Guidance for Use from a Multidisciplinary Practical Approach
Khalifa Abdullah, Magdy ElSharkawy, Emad R. Issak, et al.
International Journal of Clinical Medicine (2024) Vol. 15, Iss. 09, pp. 413-435
Open Access
Khalifa Abdullah, Magdy ElSharkawy, Emad R. Issak, et al.
International Journal of Clinical Medicine (2024) Vol. 15, Iss. 09, pp. 413-435
Open Access
Social Determinants Of Health For Cardiovascular Kidney Metabolic Syndrome Among Patients With Diabetes: Sdoh-Ckm Study
Kibret Enyew Belay, Yeweyenhareg Feleke, Theodros Aberra Alemneh, et al.
Journal of the Endocrine Society (2024) Vol. 9, Iss. 1
Open Access
Kibret Enyew Belay, Yeweyenhareg Feleke, Theodros Aberra Alemneh, et al.
Journal of the Endocrine Society (2024) Vol. 9, Iss. 1
Open Access
